[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]
A Facilities for Illness Management and Prevention advisory panel is assembly Thursday to debate a critical, however uncommon, autoimmune dysfunction linked to Johnson & Johnson’s Covid-19 vaccine.
The CDC’s Advisory Committee on Immunization Practices assembly comes a bit of over per week after the Meals and Drug Administration introduced a brand new warning label for the J&J shot after 100 preliminary studies of Guillain-Barre syndrome had been detected in J&J recipients.